Actively Recruiting
Heart Failure Virtual Ward Research Study
Led by National University of Ireland, Galway, Ireland · Updated on 2026-04-15
346
Participants Needed
1
Research Sites
132 weeks
Total Duration
On this page
Sponsors
N
National University of Ireland, Galway, Ireland
Lead Sponsor
H
Health Service Executive, Ireland
Collaborating Sponsor
AI-Summary
What this Trial Is About
The main aim will be to evaluate whether a follow-up with virtual wards reduces HF hospitalisation at three months follow-up. Hospital admission will be defined as any hospital admission, or an emergency room stay of more than 24 h requiring IV diuretics. The secondary objectives will be to evaluate whether this intervention reduces all-cause mortality, all-cause hospitalisation at three months, is cost-effectiveness, is associated with a higher percentage of prescription and dose of prognostic medication and improves the quality of life. To assess the potential long-term effects of the virtual wards follow-up, we will evaluate whether this intervention reduces all-cause mortality and HF hospitalisation at 6- and 12-months by a telephone call/virtual outpatients' appointment. The study outcomes will be ascertained at each visit. Given the study design, it is impossible to assess the endpoints in a blinded manner. Clinical events during the study will be adjudicated by an operational committee whose members will be unaware of the group assignment.
CONDITIONS
Official Title
Heart Failure Virtual Ward Research Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (18 years or older) with a recent hospitalization
- Known ejection fraction and NYHA Class
- Known or new diagnosis of Heart Failure
- Patient or caregiver able to speak and understand English or Irish
- Willing to participate in the study
- Living within the Saolta group catchment area
You will not qualify if you...
- Patients who decline to participate in the study
- Patients in palliative care or with life expectancy less than one year
- Patients discharged to skilled nursing facilities or nursing homes
- Patients with planned mitral or aortic valve intervention during or soon after admission
- Patients with planned haemodialysis
- Patients enrolled in other randomized controlled trials
- Patients considered unable to participate due to non-compliance, language barrier, or moderate to severe cognitive impairment without caregiver support
- Patients with asymptomatic (NYHA class I) left ventricular dysfunction usually after acute myocardial infarction
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Portiuncula University Hospital
Ballinasloe, Galway, Ireland, H53 T971
Actively Recruiting
Research Team
D
David Tiernan, MD
CONTACT
N
Nuria Farre, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here